Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EnCor Breast Biopsy Probe with Rinse Tube

K-Number: K210654 · 2021-03-31

ApplicantSenorx, Inc.
Decision Date2021-03-31
Product CodeKNW
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

EnCor Breast Biopsy Probe with Rinse Tube is the device name listed in this FDA 510(k) record. The listed applicant is Senorx, Inc.. It received FDA 510(k) clearance on 2021-03-31 under 510(k) number K210654. The device is classified under product code KNW. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EnCor Breast Biopsy Probe with Rinse Tube?

EnCor Breast Biopsy Probe with Rinse Tube is a medical device that received FDA 510(k) clearance on 2021-03-31. The listed applicant is Senorx, Inc.. The 510(k) number is K210654.

When did EnCor Breast Biopsy Probe with Rinse Tube receive FDA 510(k) clearance?

EnCor Breast Biopsy Probe with Rinse Tube received FDA 510(k) clearance on 2021-03-31, under 510(k) number K210654.

Who is the listed applicant for EnCor Breast Biopsy Probe with Rinse Tube?

The FDA 510(k) record lists Senorx, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EnCor Breast Biopsy Probe with Rinse Tube?

The FDA product code for EnCor Breast Biopsy Probe with Rinse Tube is KNW.

Other records listing Senorx, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KNW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.